Search
Filter Results
Displaying 961–970 of 1024 results
-
Apr 8, 2014
Total Blindness and Non-24 Sleep Disorder
Non-24 is a very rare condition affecting many (but not all) people who are totally blind and have absolutely no light perception. Their circadian clocks become out of sync as a result.
-
Mar 20, 2014
UCI Stem-Cell Pioneer Poised to Launch Clinical Trial for RP Patients
Dr. Henry Klassen’s progenitor-based therapy has the potential to rescue a variety of retinal cells — including rods, cones, retinal pigment epithelium and ganglion cells — and, therefore, may save vision in people with a wide range of conditions.
-
Jan 29, 2014
The Power of Suggestion — Challenges of the Placebo Effect
Even in a well-designed clinical trial, the placebo effect can rear its head.
-
Jan 22, 2014
Choroideremia Gene Therapy Improves Vision in Human Study
Researchers were able to improve vision in five of six people with choroideremia participating in a clinical trial.
-
Jan 14, 2014
Vision Improvements Reported in Choroideremia Gene Therapy Clinical Trial
Five of six participants in the initial study group have sustained vision improvements in their treated eyes in dim settings.
-
Dec 31, 2013
Nouvelle Lumière: French Bionic Retina in a Human Study
The French retinal implant developer Pixium quietly launched a clinical trial for its Intelligent Retinal Implant System 1 (IRIS1) in France, Austria and Germany.
-
Dec 12, 2013
Foundation Chairman, Gordon Gund, Interviewed on Forbes.com
The driving force behind the Foundation’s considerable advances covers those, as well as other compelling subjects, during a 27-minute Q&A.
-
Dec 12, 2013
FFB Chairman, Gordon Gund, Interviewed on Forbes.com
The Foundation’s chairman and co-founder, Gordon Gund is interviewed on Forbes.com
-
Dec 2, 2013
An FFB Board Member’s Perspective on Her Experience with Acupuncture
Moira Shea describes her experience with acupuncture.
-
Nov 5, 2013
Is Acupuncture a Beneficial Treatment for Retinitis Pigmentosa?
Acupuncture definitely has potential benefits, and the breadth of those is being aggressively explored.